Encision Inc. Stock

ECIA

US29254Q1040

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 23:44:04 16/04/2026 +04			5-day change	1st Jan Change
0.2010 ^USD	+18.24%		+370.73%	+43.57%

12-13	Encision Inc. Announces Management Changes	CI
12-13	Encision Inc. Announces CEO Changes	CI

Encision Inc. is a medical device company. It designs, develops, manufactures and markets patented surgical instruments that provide safety to patients undergoing minimally invasive surgery. Its segments include Product and Service. The Product segment designs, develops, manufactures and markets patented surgical instruments. The Service segment performs electrical engineering activities for external entities. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause tissue injury that may result in death. The AEM system consists of shielded 5mm AEM Instruments and an AEM monitor. Laparoscopic instruments have the integrated AEM design and include the full range of instruments that are common in laparoscopic surgery. The AEM monitor is compatible with electrosurgical generators.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
19/08/26	$0.0406	-3.33%	300
17/08/26	$0.0420	-1.64%	44,110
11/08/26	$0.0427	+22.00%	375

Real-time OTC Markets

More quotes

Income Statement and Estimates

More financial data

Stock Market
Stocks
ECIA Stock

As early as today, start finding the best investment opportunities!

Market Cap	2.19M 1.88M 1.76M 1.61M 3.03M 210M 3.08M 20.74M 8.12M 105M 8.24M 8.06M 348M	P/E 2024	-12.5x	P/E 2025	-23.9x
Enterprise Value	3.25M 2.79M 2.6M 2.39M 4.49M 311M 4.57M 30.73M 12.03M 156M 12.21M 11.94M 515M	EV / Sales 2024	1.54x	EV / Sales 2025	1.03x
Free-Float	38.58%	Yield 2024 *	-	Yield 2025	-

12-13	Encision Inc. Announces Management Changes	CI
12-13	Encision Inc. Announces CEO Changes	CI
11-14	Encision Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
11-04	Encision Inc. Announces Resignation of Patrick Pace from Its Board of Directors, Effective October 30, 2025	CI
19/08/25	Encision Inc. announced that it has received $0.5 million in funding	CI
15/08/25	Encision Inc. Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
11/07/25	Encision Inc. Reports Earnings Results for the Full Year Ended March 31, 2025	CI
15/02/25	Encision Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
15/11/24	Earnings Flash (ECIA) ENCISION Reports Fiscal Q2 Revenue $1.8M	MT
15/11/24	Encision Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
15/08/24	Encision Inc. Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
15/07/24	Earnings Flash (ECIA) ENCISION Reports Q4 Revenue $1.5M	MT
15/07/24	Encision Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

07-16	Encision : Announces Start of Stock Trading	PU
07-14	Encision Inc. Announces Start of Stock Trading	AQ
05-04	Encision Inc. Announces Halt of Stock Trading	AQ
04-13	Encision Inc. Announces Fiscal 2026 Fourth Quarter and Full Year Results	AQ
01-30	Encision : Announces Decision to Deregister its Common Stock	PU

1 day	+18.24%
1 week	+370.73%
Current month	+67.50%
1 month	+344.69%
6 months	+34.00%
Current year	+43.57%

1 week	0.04	0.2
1 month	0.04	0.2
Current year	0	0.2
1 year	0	0.4
3 years	0	0.75
5 years	0	1.5
10 years	0	1.5

Encision Inc. Stock

Stocks

ECIA

US29254Q1040

Medical Equipment, Supplies & Distribution

Valuation: Encision Inc.

Chart: Encision Inc.

Latest news : Encision Inc.

Press Releases: Encision Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Encision Inc.

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Income Statement and Estimates

Manager	Title	Age	Since
Robert Fries CEO	Chief Executive Officer	77	08/12/2025
Brandon Shepard DFI	Director of Finance/CFO	42	01/08/2024
Denise Baker LAW	General Counsel	-	01/01/2019

Director	Title	Age	Since
Vern Kornelsen BRD	Director/Board Member	93	01/01/1991
Robert Fries BRD	Director/Board Member	77	17/04/2024

Date	Insider	Type	Main position	Quantity	% Market Cap.
18/11/25	Gregory Trudel	Free	Chief Executive Officer	10,000	0.0592%
18/11/25	Brian Jackman	Free	VP of Marketing	10,000	0.0592%
18/11/25	Vern Kornelsen	Free	Founder	10,000	0.0592%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ENCISION INC.	+18.24%	+370.73%	-4.29%	-56.30%	685K
ABBOTT LABORATORIES	+1.55%	+3.17%	-12.82%	+10.34%	198B
MEDTRONIC PLC	+2.22%	+3.71%	+4.71%	+15.47%	120B
CENCORA, INC.	+0.31%	+0.93%	+7.60%	+75.78%	60.51B
HOYA CORPORATION	-0.69%	-4.97%	+30.57%	+60.51%	53.64B
BECTON, DICKINSON AND COMPANY	+3.78%	+2.19%	-5.27%	-31.46%	51.1B
DEXCOM, INC.	+0.31%	-1.01%	+11.10%	-15.25%	33.92B
MEDLINE INC.	-0.62%	-4.48%	-	-	29.75B
WEST PHARMACEUTICAL SERVICES, INC.	+1.79%	+0.14%	+42.84%	-9.02%	24.83B
TERUMO CORPORATION	+4.23%	-1.68%	-6.80%	+25.10%	23.01B
Average	+2.68%	-0.25%	+7.52%	+8.35%	59.52B
Weighted average by Cap.	+0.40%	+1.42%	+2.02%	+17.63%

	2024	2025
Net sales	6.59M 5.65M 5.28M 4.84M 9.1M 629M 9.25M 62.25M 24.37M 316M 24.73M 24.19M 1.04B	6.56M 5.62M 5.25M 4.82M 9.06M 627M 9.21M 61.96M 24.26M 314M 24.61M 24.08M 1.04B
Net income	-692K -593K -554K -508K -956K -66.12M -972K -6.54M -2.56M -33.16M -2.6M -2.54M -110M	-220K -189K -176K -162K -304K -21.05M -309K -2.08M -815K -10.56M -827K -809K -34.9M
Net Debt	1.29M 1.11M 1.03M 949K 1.78M 123M 1.81M 12.2M 4.78M 61.87M 4.85M 4.74M 205M	1.06M 906K 846K 777K 1.46M 101M 1.48M 9.99M 3.91M 50.66M 3.97M 3.88M 167M